nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0235	0.0345	CbGpPWpGaD
Orphenadrine—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.023	0.0338	CbGpPWpGaD
Orphenadrine—GRIN1—midbrain—nicotine dependence	0.0222	0.0954	CbGeAlD
Orphenadrine—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.0184	0.0269	CbGpPWpGaD
Orphenadrine—SCN9A—midbrain—nicotine dependence	0.0174	0.0748	CbGeAlD
Orphenadrine—GRIN2D—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.0172	0.0252	CbGpPWpGaD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.0163	0.0238	CbGpPWpGaD
Orphenadrine—GRIN2D—brain—nicotine dependence	0.0157	0.0673	CbGeAlD
Orphenadrine—SCN5A—cardiovascular system—nicotine dependence	0.0154	0.0662	CbGeAlD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.0154	0.0226	CbGpPWpGaD
Orphenadrine—SCN1A—midbrain—nicotine dependence	0.015	0.0643	CbGeAlD
Orphenadrine—GRIN3A—brain—nicotine dependence	0.0147	0.0633	CbGeAlD
Orphenadrine—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.0146	0.0214	CbGpPWpGaD
Orphenadrine—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.0143	0.0209	CbGpPWpGaD
Orphenadrine—GRIN1—brain—nicotine dependence	0.014	0.06	CbGeAlD
Orphenadrine—CHRM2—cardiovascular system—nicotine dependence	0.0131	0.0564	CbGeAlD
Orphenadrine—GRIN1—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.0123	0.018	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0122	0.0179	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.0116	0.0171	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0116	0.017	CbGpPWpGaD
Orphenadrine—Levomethadyl Acetate—CHRNB4—nicotine dependence	0.0114	0.19	CrCbGaD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.0111	0.0163	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.011	0.0162	CbGpPWpGaD
Orphenadrine—SCN9A—brain—nicotine dependence	0.0109	0.047	CbGeAlD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.0107	0.0157	CbGpPWpGaD
Orphenadrine—Methadyl Acetate—OPRM1—nicotine dependence	0.0104	0.172	CrCbGaD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00993	0.0146	CbGpPWpGaD
Orphenadrine—SCN4A—brain—nicotine dependence	0.00977	0.0419	CbGeAlD
Orphenadrine—KCNH2—cardiovascular system—nicotine dependence	0.00949	0.0407	CbGeAlD
Orphenadrine—SCN1A—brain—nicotine dependence	0.00942	0.0404	CbGeAlD
Orphenadrine—GRIN2D—Neuronal System—CHRNB3—nicotine dependence	0.00937	0.0137	CbGpPWpGaD
Orphenadrine—Methadone—CHRNA10—nicotine dependence	0.00933	0.155	CrCbGaD
Orphenadrine—GRIN2D—Neuronal System—CHRNA6—nicotine dependence	0.00888	0.013	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00876	0.0128	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00838	0.0123	CbGpPWpGaD
Orphenadrine—SCN10A—brain—nicotine dependence	0.00834	0.0358	CbGeAlD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0083	0.0122	CbGpPWpGaD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.0081	0.0119	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00803	0.0118	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00798	0.0117	CbGpPWpGaD
Orphenadrine—Levomethadyl Acetate—CHRNA3—nicotine dependence	0.00792	0.132	CrCbGaD
Orphenadrine—CYP2B6—cardiovascular system—nicotine dependence	0.00779	0.0334	CbGeAlD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00765	0.0112	CbGpPWpGaD
Orphenadrine—SCN5A—brain—nicotine dependence	0.00758	0.0325	CbGeAlD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00747	0.011	CbGpPWpGaD
Orphenadrine—KCNH2—midbrain—nicotine dependence	0.00741	0.0318	CbGeAlD
Orphenadrine—CYP2E1—cardiovascular system—nicotine dependence	0.00731	0.0314	CbGeAlD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00713	0.0105	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00712	0.0104	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00702	0.0103	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—CHRNB3—nicotine dependence	0.00671	0.00984	CbGpPWpGaD
Orphenadrine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00663	0.00972	CbGpPWpGaD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00647	0.00949	CbGpPWpGaD
Orphenadrine—CHRM2—brain—nicotine dependence	0.00645	0.0277	CbGeAlD
Orphenadrine—GRIN2D—Neuronal System—GABRA4—nicotine dependence	0.00642	0.00941	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—CHRNA6—nicotine dependence	0.00636	0.00933	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—CHRNB4—nicotine dependence	0.00616	0.00902	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00609	0.00893	CbGpPWpGaD
Orphenadrine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00606	0.00888	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00603	0.00884	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.006	0.0088	CbGpPWpGaD
Orphenadrine—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00598	0.00876	CbGpPWpGaD
Orphenadrine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00593	0.0087	CbGpPWpGaD
Orphenadrine—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00585	0.00858	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00585	0.00857	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.0058	0.00851	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00575	0.00844	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—CHRNA5—nicotine dependence	0.00572	0.00839	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.00559	0.00819	CbGpPWpGaD
Orphenadrine—HRH1—Monoamine GPCRs—DRD2—nicotine dependence	0.00541	0.00792	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00536	0.00786	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00535	0.00784	CbGpPWpGaD
Orphenadrine—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00532	0.0078	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.0053	0.00777	CbGpPWpGaD
Orphenadrine—SLC6A2—brain—nicotine dependence	0.00519	0.0223	CbGeAlD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00511	0.00749	CbGpPWpGaD
Orphenadrine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00491	0.0072	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00487	0.00714	CbGpPWpGaD
Orphenadrine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00481	0.00705	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00468	0.00687	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—CHRNA3—nicotine dependence	0.00466	0.00684	CbGpPWpGaD
Orphenadrine—KCNH2—brain—nicotine dependence	0.00466	0.02	CbGeAlD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00464	0.0068	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—GABRA4—nicotine dependence	0.0046	0.00674	CbGpPWpGaD
Orphenadrine—HRH1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00454	0.00666	CbGpPWpGaD
Orphenadrine—Levomethadyl Acetate—OPRM1—nicotine dependence	0.00451	0.075	CrCbGaD
Orphenadrine—Mydriasis—Varenicline—nicotine dependence	0.00447	0.181	CcSEcCtD
Orphenadrine—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00447	0.00655	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—CHRNB4—nicotine dependence	0.00441	0.00646	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00436	0.00639	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00425	0.00624	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—CHRNB2—nicotine dependence	0.00411	0.00602	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0041	0.00601	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—CHRNA5—nicotine dependence	0.0041	0.00601	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00402	0.0059	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0039	0.00572	CbGpPWpGaD
Orphenadrine—Dextropropoxyphene—OPRM1—nicotine dependence	0.0039	0.0648	CrCbGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00384	0.00563	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.00383	0.00562	CbGpPWpGaD
Orphenadrine—CYP2B6—brain—nicotine dependence	0.00382	0.0164	CbGeAlD
Orphenadrine—HRH1—brain—nicotine dependence	0.00373	0.016	CbGeAlD
Orphenadrine—GRIN2D—Neuronal System—CHRNA4—nicotine dependence	0.00373	0.00547	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.00367	0.00538	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00365	0.00536	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00363	0.00532	CbGpPWpGaD
Orphenadrine—CYP2E1—brain—nicotine dependence	0.00359	0.0154	CbGeAlD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00354	0.00519	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00349	0.00511	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.00341	0.00501	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—CHRNA3—nicotine dependence	0.00334	0.0049	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00311	0.00456	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—CHRNB2—nicotine dependence	0.00294	0.00431	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.00278	0.00408	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00277	0.00406	CbGpPWpGaD
Orphenadrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00275	0.00403	CbGpPWpGaD
Orphenadrine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00272	0.00398	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00271	0.00397	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—CHRNA4—nicotine dependence	0.00267	0.00392	CbGpPWpGaD
Orphenadrine—Methadone—OPRM1—nicotine dependence	0.00264	0.0439	CrCbGaD
Orphenadrine—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00261	0.00382	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00257	0.00377	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.00255	0.00374	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00255	0.00374	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00252	0.00369	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.00245	0.00359	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00245	0.00359	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00223	0.00327	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00223	0.00327	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.00223	0.00326	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.0022	0.00322	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00208	0.00304	CbGpPWpGaD
Orphenadrine—Amitriptyline—OPRM1—nicotine dependence	0.00205	0.0342	CrCbGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00189	0.00276	CbGpPWpGaD
Orphenadrine—Hallucination—Varenicline—nicotine dependence	0.00178	0.0721	CcSEcCtD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00159	0.00234	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00153	0.00224	CbGpPWpGaD
Orphenadrine—Trimipramine—DRD2—nicotine dependence	0.00153	0.0254	CrCbGaD
Orphenadrine—Promethazine—DRD2—nicotine dependence	0.00147	0.0245	CrCbGaD
Orphenadrine—Vision blurred—Varenicline—nicotine dependence	0.00147	0.0595	CcSEcCtD
Orphenadrine—Tremor—Varenicline—nicotine dependence	0.00146	0.0591	CcSEcCtD
Orphenadrine—Doxepin—DRD2—nicotine dependence	0.00146	0.0242	CrCbGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00144	0.00212	CbGpPWpGaD
Orphenadrine—Agitation—Varenicline—nicotine dependence	0.00143	0.058	CcSEcCtD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00142	0.00208	CbGpPWpGaD
Orphenadrine—Palpitations—Varenicline—nicotine dependence	0.00138	0.0558	CcSEcCtD
Orphenadrine—Promazine—DRD2—nicotine dependence	0.00129	0.0215	CrCbGaD
Orphenadrine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00126	0.00185	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00126	0.00184	CbGpPWpGaD
Orphenadrine—Tachycardia—Varenicline—nicotine dependence	0.00124	0.0503	CcSEcCtD
Orphenadrine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00124	0.00182	CbGpPWpGaD
Orphenadrine—Skin disorder—Varenicline—nicotine dependence	0.00124	0.05	CcSEcCtD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00124	0.00181	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00122	0.00178	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00118	0.00174	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00117	0.00171	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00115	0.00168	CbGpPWpGaD
Orphenadrine—Imipramine—DRD2—nicotine dependence	0.00113	0.0188	CrCbGaD
Orphenadrine—Somnolence—Varenicline—nicotine dependence	0.00113	0.0458	CcSEcCtD
Orphenadrine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00113	0.00165	CbGpPWpGaD
Orphenadrine—Amitriptyline—DRD2—nicotine dependence	0.00113	0.0187	CrCbGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00111	0.00162	CbGpPWpGaD
Orphenadrine—Constipation—Varenicline—nicotine dependence	0.00109	0.044	CcSEcCtD
Orphenadrine—Feeling abnormal—Varenicline—nicotine dependence	0.00105	0.0424	CcSEcCtD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00104	0.00153	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00103	0.0015	CbGpPWpGaD
Orphenadrine—Urticaria—Varenicline—nicotine dependence	0.00101	0.0409	CcSEcCtD
Orphenadrine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.00099	0.00145	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000974	0.00143	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000941	0.00138	CbGpPWpGaD
Orphenadrine—Hypersensitivity—Varenicline—nicotine dependence	0.000938	0.0379	CcSEcCtD
Orphenadrine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000926	0.00136	CbGpPWpGaD
Orphenadrine—Asthenia—Varenicline—nicotine dependence	0.000913	0.037	CcSEcCtD
Orphenadrine—Pruritus—Varenicline—nicotine dependence	0.000901	0.0364	CcSEcCtD
Orphenadrine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.000899	0.00132	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000894	0.00131	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000885	0.0013	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000879	0.00129	CbGpPWpGaD
Orphenadrine—Dizziness—Varenicline—nicotine dependence	0.000842	0.0341	CcSEcCtD
Orphenadrine—Vomiting—Varenicline—nicotine dependence	0.00081	0.0327	CcSEcCtD
Orphenadrine—Headache—Varenicline—nicotine dependence	0.000798	0.0323	CcSEcCtD
Orphenadrine—Nausea—Varenicline—nicotine dependence	0.000756	0.0306	CcSEcCtD
Orphenadrine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	0.000681	0.000998	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	0.000677	0.000992	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.00067	0.000982	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000666	0.000977	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000532	0.00078	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGD1—nicotine dependence	0.000531	0.000779	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000523	0.000767	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000523	0.000766	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	0.000483	0.000708	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000475	0.000697	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	0.000469	0.000688	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000462	0.000677	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000446	0.000654	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000437	0.00064	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	0.000385	0.000564	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000378	0.000555	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	0.000349	0.000512	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000344	0.000504	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—WASF2—nicotine dependence	0.000331	0.000485	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000325	0.000477	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—WASF1—nicotine dependence	0.000317	0.000465	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000312	0.000457	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	0.000285	0.000418	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000281	0.000412	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DRD2—nicotine dependence	0.000206	0.000302	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000203	0.000298	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000203	0.000297	CbGpPWpGaD
